文献速递糖尿病肥胖与代谢综合征

血浆神经酰胺与内脏脂肪、胰岛素抵抗及2型糖尿病发生的关系:Dallas心脏研究

Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.
PubMed 文献 · Diabetologia · 2018-08-29

研究纳入1557例无2型糖尿病的Dallas心脏研究参与者,检测基线血浆神经酰胺、MRI脂肪分布和代谢标志物,随访7年评估糖尿病结局。内脏脂肪与饱和脂肪酸神经酰胺正相关、与多不饱和神经酰胺负相关,HOMA-IR呈相似模式;校正临床因素后神经酰胺与2型糖尿病发生无关联。

要点

  • 内脏脂肪与饱和脂肪酸神经酰胺正相关(每SD β=0.16~0.18),与多不饱和神经酰胺负相关(β=-0.14~-0.16)。
  • HOMA-IR与饱和神经酰胺正相关(β=0.08~0.09),与多不饱和神经酰胺负相关(β=-0.06~-0.07)。
  • 校正临床因素后,神经酰胺与2型糖尿病发生无关联。

核心结论

  • 血浆神经酰胺与功能失调性肥胖的代谢和影像学指标呈现生物学上复杂的关系。
  • 神经酰胺在连接内脏肥胖与胰岛素抵抗的共同代谢功能障碍通路中的作用尚需进一步研究。

研究设计与样本

  • Dallas心脏研究中1557例无2型糖尿病参与者,基线测量代谢生物标志物、MRI脂肪库和液相色谱-质谱法血浆神经酰胺,7年后评估糖尿病结局。
  • 队列平均年龄43岁,女性58%,黑人45%,平均BMI 28 kg/m2。

主要发现

  • 总胆固醇与所有神经酰胺相关;较高甘油三酯、较低HDL-胆固醇和脂联素仅与饱和脂肪酸链神经酰胺相关(p<0.0003)。
  • 校正临床特征和全身脂肪后,内脏脂肪与饱和脂肪酸神经酰胺正相关(每SD β=0.16~0.18),与多不饱和脂肪酸神经酰胺负相关(β=-0.14~-0.16,p<0.001)。
  • 下身皮下脂肪呈现与内脏脂肪相反的模式。
  • HOMA-IR与饱和神经酰胺正相关(β=0.08~0.09,p<0.001),与多不饱和神经酰胺负相关(β=-0.06~-0.07,p<0.05)。
  • 校正临床因素后,神经酰胺与2型糖尿病发生无关联。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Ceramides are sphingolipids that contribute to insulin resistance in preclinical studies. We hypothesised that plasma ceramides would be associated with body fat distribution, insulin resistance and incident type 2 diabetes in a multi-ethnic cohort. METHODS: A total of 1557 participants in the Dallas Heart Study without type 2 diabetes underwent measurements of metabolic biomarkers, fat depots by MRI and plasma ceramides by liquid chromatography-mass spectrometry. Diabetes outcomes were assessed after 7 years. Associations of body fat and insulin resistance with ceramides at baseline and of ceramides with incident diabetes outcomes were analysed. RESULTS: The cohort had a mean age of 43 years, with 58% women, 45% black participants and a mean BMI of 28 kg/m2. Total cholesterol levels were associated with all ceramides, but higher triacylglycerols and lower HDL-cholesterol and adiponectin were associated only with saturated fatty acid chain ceramides (p < 0.0003). After adjusting for clinical characteristics and total body fat, visceral adipose tissue was positively associated with saturated fatty acid ceramides (per SD, β = 0.16 to 0.18) and inversely associated with polyunsaturated fatty acid ceramides (β = -0.14 to -0.16, p < 0.001 for all). Lower-body subcutaneous fat showed an opposite pattern to that for visceral fat. HOMA-IR was positively associated with saturated (β = 0.08 to 0.09, p < 0.001) and inversely with polyunsaturated ceramides (β = -0.06 to -0.07, p < 0.05). Ceramides were not associated with incident type 2 diabetes after adjustment for clinical factors. CONCLUSIONS/INTERPRETATION: Plasma ceramides demonstrate a biologically complex relationship with metabolic and imaging indicators of dysfunctional adiposity. The role of ceramides in a shared pathway of metabolic dysfunction linking visceral adiposity and insulin resistance requires further investigation.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Neeland IJ, Singh S, McGuire DK, et al. Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study. Diabetologia. 2018. PMID: 30159588. doi:10.1007/s00125-018-4720-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。